Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ) Stock Price: $237.00+4.84 (+2.08%)
The total return cagr for Johnson & Johnson (JNJ) stock is 56.54% over the past 12 months. The 3 year average growth rate is 17.36% and the 5 year cagr is 10.50%. Total return includes dividends reinvested.
The closing share price for Johnson & Johnson (JNJ) stock was $237.00 for Tuesday, June 9, 2026, up +2.08% from the previous day.
JNJ Price Chart
End-of-day pricesAdvanced chart →
JNJ$237.00▲ 55.53%as of Jun 9, 2026
JNJ Key Metrics
See All MetricsJNJ Earnings Preview
Next Earnings Date
Jul 15, 2026
36 days away
EPS Estimate
2.85
Revenue Est.
$24.96B
Last Quarter Results
EPS
$2.70
vs Estimate
$2.68
Met
Revenue
$24.06B
vs Estimate
$23.61B
Beat
JNJ Analyst Ratings
Consensus Rating
Buy
Based on 23 analysts
Strong Buy
5
Buy
10
Hold
8
Sell
0
Strong Sell
1
Average Price Target
$252.87
+6.7% upside
Low
$155.00
Current
$237.00
High
$285.00
JNJ Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $2.94 | N/A | 5 |
| Q2 2027 | N/A | $3.11 | N/A | 5 |
| Q3 2027 | N/A | $3.21 | N/A | 5 |
| Q4 2027 | N/A | $3.33 | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $12.77 | N/A | 13 |
| FY 2028 | N/A | $14.03 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $25.13B | N/A | 5 |
| Q2 2027 | N/A | $26.26B | N/A | 5 |
| Q3 2027 | N/A | $26.96B | N/A | 5 |
| Q4 2027 | N/A | $28.75B | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $107.75B | N/A | 13 |
| FY 2028 | N/A | $114.99B | N/A | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
Related Stocks
HealthcareJNJ Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1JNJ | $570.51B | $237.00 | +2.08% | +56.54% | +10.50% | +10.29% |
| 2PFE | $146.48B | $25.70 | +0.31% | +14.76% | -3.54% | +1.93% |
| 3MRK | $295.39B | $119.60 | +0.07% | +56.29% | +13.58% | +11.55% |
| 4ABBV | $398.27B | $225.42 | +1.05% | +23.10% | +19.01% | +18.82% |
| 5LLY | $1.08T | $1144.03 | -0.45% | +48.94% | +39.63% | +33.56% |
| 6BMY | $115.34B | $56.48 | +1.64% | +21.06% | +1.10% | +0.95% |
JNJ Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt